Aqueous-based microcapsules are detected primarily in gut-associated dendritic cells after oral inoculation of mice

E A Lomotan1, K A Brown, T J Speaker

  • 1Section of Infectious Diseases, Children's Hospital of Philadelphia, PA, USA.

Vaccine
|December 31, 1997
PubMed

Insights

Microencapsulation enhances oral vaccine immunity by targeting immune cells in the gut. Spermine-alginate microcapsules are found in specific dendritic cells, suggesting a mechanism for improved immune responses.

Area of Science:

  • Immunology
  • Vaccinology
  • Materials Science

Background:

  • Aqueous-based microencapsulation previously enhanced oral virus-specific humoral immune responses in mice.
  • The underlying mechanism for this enhanced immunogenicity remains poorly understood.

Purpose of the Study:

  • To elucidate the mechanism by which microencapsulation enhances immunogenicity after oral inoculation.
  • To identify the immune cells involved in the enhanced response.

Main Methods:

  • Oral inoculation of adult mice with spermine-alginate microcapsules.
  • Detection and characterization of microcapsules within immune cells in gut-associated lymphoid tissue.

Main Results:

  • Spermine-alginate microcapsules were primarily detected in gut-associated dendritic cells (CD11c/CD18+, Ia+, CD11b-, CD45R-).
  • These findings suggest a role for antigen-presenting cells in the enhanced immunogenicity.

Conclusions:

  • Microencapsulation may enhance immunogenicity by engaging more efficient antigen-presenting cells compared to natural infection.
  • This study provides insights into the cellular mechanisms of microencapsulation-mediated vaccine enhancement.

Related Concept Videos